rank,protein_id,score,known_target,associated_adverse_effects,reasoning
1,RET - ret proto-oncogene (human),1.0,True,,"Path 1: Pralsetinib --[inhibits]--> RET - ret proto-oncogene (human) (evidence: 0.3 nM (IC50 (AID: 1934929). Path 2: No (RET - ret proto-oncogene (human), associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
2,RET,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> RET (evidence: Active nan (Proto-oncogene c-Ret (RET). Path 2: No (RET, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
3,HRAS,1.0,False,,"Path 1: No (Pralsetinib, inhibits, HRAS) edge in KG; GNN predicts link (score=1.0000). Path 2: No (HRAS, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
4,CCDC6,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> CCDC6 (evidence: Active nan (CCDC6). Path 2: No (CCDC6, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
5,KDR,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> KDR (evidence: Active nan (kinase insert domain receptor). Path 2: No (KDR, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
6,KIF5B,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> KIF5B (evidence: Active nan (KIF5B). Path 2: No (KIF5B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
7,EML4,1.0,False,,"Path 1: No (Pralsetinib, inhibits, EML4) edge in KG; GNN predicts link (score=1.0000). Path 2: No (EML4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
8,DRD2,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> DRD2 (evidence: Active nan (DRD2). Path 2: No (DRD2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
9,PTK2B,1.0,True,,"Path 1: Pralsetinib --[inhibits]--> PTK2B (evidence: Active nan (PTK2B). Path 2: No (PTK2B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
10,Tyrosine-protein kinase JAK2 (human),1.0,True,"Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Refractory, with Excess of Blasts | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Basal Ganglia Cerebrovascular Disease | Bone Marrow Neoplasms | Bone Neoplasms | Brachydactyly with hypertension | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Islet Cell | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Lobular | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardiac Tamponade | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Extrahepatic | Cholestasis, Intrahepatic | Cholestasis, progressive familial intrahepatic 3 | Choriocarcinoma | Choroidal Neovascularization | Clear-cell metastatic renal cell carcinoma | Colitis-Associated Neoplasms | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Corneal Neovascularization | Cystadenocarcinoma | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endocrine Gland Neoplasms | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Essential Hypertension | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Genital Neoplasms, Male | Giant Cell Tumor of Bone | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypothyroidism | IMMUNE SUPPRESSION | Idiopathic intracranial hypertension with papilledema | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Large Granular Lymphocytic | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Acute | Leukemia, Myelomonocytic, Chronic | Leukemia, Plasma Cell | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Diseases, Parasitic | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Meningeal Carcinomatosis | Mesenteric Vascular Occlusion | Mixed Tumor, Mullerian | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Fibrous Tissue | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Radiation-Induced | Neoplasms, Second Primary | Neoplasms, Squamous Cell | Neoplasms, Unknown Primary | Neovascularization, Pathologic | Nervous System Neoplasms | Neuritis, Autoimmune, Experimental | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neuroendocrine Tumors | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Pregnancy Complications, Cardiovascular | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Aminoacidurias | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sinus Arrest, Cardiac | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Headaches | Vascular Malformations | Vascular Neoplasms | Vascular Remodeling | Vascular System Injuries | Vulvar Neoplasms | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> Tyrosine-protein kinase JAK2 (human) (evidence: 2.0 nM (IC50 (AID: 1776972). Path 2: Tyrosine-protein kinase JAK2 (human) --[associated_with]--> Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases ... (+267 more)."
11,FLT3 - fms related receptor tyrosine kinase 3 (human),1.0,True,"Acidosis, Renal Tubular | Acute Lung Injury | Acute erythroleukemia | Adenocarcinoma | Adenocarcinoma of Lung | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Refractory, with Excess of Blasts | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Bone Marrow Neoplasms | Brain Neoplasms | Brain Stem Neoplasms | Breast Neoplasms | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoma | Carcinoma in Situ | Carcinoma, Bronchogenic | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Tamponade | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Choriocarcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hypertension | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypothyroidism | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia, Experimental | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myeloid, Chronic-Phase | Leukemia, Myelomonocytic, Chronic | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Large-Cell, Anaplastic | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Experimental | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neovascularization, Pathologic | Neuroectodermal Tumors | Neuroendocrine Tumors | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudotumor Cerebri | Rectal Neoplasms | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sinus Arrest, Cardiac | Skin Neoplasms | Small Cell Lung Carcinoma | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> FLT3 - fms related receptor tyrosine kinase 3 (human) (evidence: 6.5 nM (IC50 (AID: 1776973). Path 2: FLT3 - fms related receptor tyrosine kinase 3 (human) --[associated_with]--> Acidosis, Renal Tubular | Acute Lung Injury | Acute erythroleukemia | Adenocarcinoma | Adenocarcinoma of Lung | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency ... (+194 more)."
12,KDR - kinase insert domain receptor (human),1.0,True,"Abdominal Neoplasms | Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Diamond-Blackfan | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Refractory, with Excess of Blasts | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brachydactyly with hypertension | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Islet Cell | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Lobular | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Signet Ring Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardiac Tamponade | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebellar Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Extrahepatic | Cholestasis, Intrahepatic | Choriocarcinoma | Choroidal Neovascularization | Clear-cell metastatic renal cell carcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Corneal Neovascularization | Cystadenocarcinoma | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Diabetes Mellitus, Congenital Autoimmune | Disseminated Intravascular Coagulation | Duodenal Neoplasms | Ear Neoplasms | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Essential Hypertension | Euthyroid Sick Syndromes | Eye Neoplasms | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastro-enteropancreatic neuroendocrine tumor | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Glycosuria, Renal | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hepatorenal Syndrome | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypothyroidism | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia P388 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Hairy Cell | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | Leukemia, Myelomonocytic, Chronic | Leukemia, Myelomonocytic, Juvenile | Leukemia, Plasma Cell | Leukemia, Prolymphocytic, T-Cell | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Fungal | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Large-Cell, Anaplastic | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Primary Effusion | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Meningeal Carcinomatosis | Mesenteric Vascular Occlusion | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Mesothelial | Neoplasms, Multiple Primary | Neovascularization, Pathologic | Nervous System Neoplasms | Neuroectodermal Tumor, Melanotic | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neuroendocrine Tumors | Neutropenia | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Parotid Neoplasms | Peripheral Vascular Diseases | Peritoneal Neoplasms | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Pregnancy Complications, Cardiovascular | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Aminoacidurias | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sigmoid Neoplasms | Sinus Arrest, Cardiac | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Neoplasms | Thymus Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Thyroiditis | Thyroiditis, Autoimmune | Tongue Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Neoplasms | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> KDR - kinase insert domain receptor (human) (evidence: 35.0 nM (IC50 (AID: 1895759). Path 2: KDR - kinase insert domain receptor (human) --[associated_with]--> Abdominal Neoplasms | Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms ... (+268 more)."
13,KIF5B - kinesin family member 5B (human),1.0,True,"Abdominal Neoplasms | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Papillary | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Renal Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Cholestasis, progressive familial intrahepatic 3 | Choriocarcinoma | Choroidal Neovascularization | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Disseminated Intravascular Coagulation | Ear Neoplasms | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Genital Neoplasms, Female | Genital Neoplasms, Male | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypothyroidism | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mixed Tumor, Mullerian | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Mesothelial | Neoplasms, Radiation-Induced | Neovascularization, Pathologic | Nerve Sheath Neoplasms | Neuroectodermal Tumors, Primitive, Peripheral | Neutropenia | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Diseases | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Tongue Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> KIF5B - kinesin family member 5B (human) (evidence: 4.0 nM (GI50 (AID: 1704858). Path 2: KIF5B - kinesin family member 5B (human) --[associated_with]--> Abdominal Neoplasms | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Papillary | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Insufficiency ... (+204 more)."
14,CCDC6 - coiled-coil domain containing 6 (human),1.0,True,"Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brain Neoplasms | Breast Neoplasms | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Signet Ring Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Choriocarcinoma | Clear-cell metastatic renal cell carcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Diabetes Mellitus, Congenital Autoimmune | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Familial primary gastric lymphoma | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Genital Neoplasms, Female | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatorenal Syndrome | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypopharyngeal Neoplasms | Hypothyroidism | Hypothyroidism, Autoimmune | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Plasma Cell | Leukemia, Prolymphocytic, T-Cell | Leukemia, Promyelocytic, Acute | Leukemia, Radiation-Induced | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Primary Effusion | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neoplasms, Mesothelial | Neovascularization, Pathologic | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Paraquat lung | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Salivary Gland Neoplasms | Sigmoid Neoplasms | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> CCDC6 - coiled-coil domain containing 6 (human) (evidence: 0.4 nM (IC50 (AID: 1895760). Path 2: CCDC6 - coiled-coil domain containing 6 (human) --[associated_with]--> Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic ... (+222 more)."
15,Proto-oncogene tyrosine-protein kinase receptor Ret (human),1.0,True,,"Path 1: Pralsetinib --[inhibits]--> Proto-oncogene tyrosine-protein kinase receptor Ret (human) (evidence: 0.4 nM (IC50 (AID: 2091116). Path 2: No (Proto-oncogene tyrosine-protein kinase receptor Ret (human), associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
16,KIF11,0.4195647537708282,False,,"Path 1: No (Pralsetinib, inhibits, KIF11) edge in KG; GNN predicts link (score=0.4196). Path 2: No (KIF11, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
17,HNRNPF,0.0157736465334892,False,,"Path 1: No (Pralsetinib, inhibits, HNRNPF) edge in KG; GNN predicts link (score=0.0158). Path 2: No (HNRNPF, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
18,NEK3,0.0003472678363323,False,,"Path 1: No (Pralsetinib, inhibits, NEK3) edge in KG; GNN predicts link (score=0.0003). Path 2: No (NEK3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
19,CCNH,1.3771022167929914e-05,False,,"Path 1: No (Pralsetinib, inhibits, CCNH) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CCNH, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
20,LUM,8.19105707705603e-07,False,,"Path 1: No (Pralsetinib, inhibits, LUM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (LUM, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
21,PRKX,5.6344667598295934e-08,False,,"Path 1: No (Pralsetinib, inhibits, PRKX) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRKX, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
22,BMX,5.550210513405318e-09,False,,"Path 1: No (Pralsetinib, inhibits, BMX) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BMX, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
23,CLCN6,7.865553763863885e-10,False,,"Path 1: No (Pralsetinib, inhibits, CLCN6) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLCN6, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
24,ALDH3A2,1.3883713623208394e-10,False,,"Path 1: No (Pralsetinib, inhibits, ALDH3A2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ALDH3A2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
25,IRAK1,2.648641549141129e-11,False,,"Path 1: No (Pralsetinib, inhibits, IRAK1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (IRAK1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
26,SMARCA4,5.3403570628163255e-12,False,,"Path 1: No (Pralsetinib, inhibits, SMARCA4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SMARCA4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
27,SMARCA2,1.0866224369951438e-12,False,,"Path 1: No (Pralsetinib, inhibits, SMARCA2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SMARCA2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
28,SCNN1B,2.5189269073355725e-13,False,,"Path 1: No (Pralsetinib, inhibits, SCNN1B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SCNN1B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
29,FLT3,7.373164985459078e-14,False,,"Path 1: No (Pralsetinib, inhibits, FLT3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FLT3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
30,FXR1,7.255850922264356e-14,False,,"Path 1: No (Pralsetinib, inhibits, FXR1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FXR1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
31,ATP1A2,2.1785102950647e-14,False,,"Path 1: No (Pralsetinib, inhibits, ATP1A2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ATP1A2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
32,BCAM,6.499709438338242e-15,False,,"Path 1: No (Pralsetinib, inhibits, BCAM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BCAM, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
33,KNTC1,1.931915710712924e-15,False,,"Path 1: No (Pralsetinib, inhibits, KNTC1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (KNTC1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
34,VASP,6.388620537910248e-16,False,,"Path 1: No (Pralsetinib, inhibits, VASP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (VASP, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
35,PDLIM4,2.1760079215104943e-16,False,,"Path 1: No (Pralsetinib, inhibits, PDLIM4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PDLIM4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
36,CSRP3,7.510478354159331e-17,False,,"Path 1: No (Pralsetinib, inhibits, CSRP3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CSRP3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
37,CPT1A,2.523875287048322e-17,False,,"Path 1: No (Pralsetinib, inhibits, CPT1A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CPT1A, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
38,IDH3A,8.354730981938718e-18,False,,"Path 1: No (Pralsetinib, inhibits, IDH3A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (IDH3A, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
39,SELENOP,2.7840031169760884e-18,False,,"Path 1: No (Pralsetinib, inhibits, SELENOP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SELENOP, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
40,NUP153,8.927380882178819e-19,False,,"Path 1: No (Pralsetinib, inhibits, NUP153) edge in KG; GNN predicts link (score=0.0000). Path 2: No (NUP153, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
41,CLK3,2.8625856887589323e-19,False,,"Path 1: No (Pralsetinib, inhibits, CLK3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLK3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
42,ACADVL,8.837045133716756e-20,False,,"Path 1: No (Pralsetinib, inhibits, ACADVL) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ACADVL, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
43,CEBPA,2.663452263732705e-20,False,,"Path 1: No (Pralsetinib, inhibits, CEBPA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CEBPA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
44,PRIM2,8.161803220964228e-21,False,,"Path 1: No (Pralsetinib, inhibits, PRIM2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRIM2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
45,OGA,3.0668767303072697e-21,False,,"Path 1: No (Pralsetinib, inhibits, OGA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (OGA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
46,DSCAM,3.0251743874136657e-21,False,,"Path 1: No (Pralsetinib, inhibits, DSCAM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (DSCAM, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
47,LY75,2.9969409925069337e-21,False,,"Path 1: No (Pralsetinib, inhibits, LY75) edge in KG; GNN predicts link (score=0.0000). Path 2: No (LY75, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
48,CREBL2,2.937719626630182e-21,False,,"Path 1: No (Pralsetinib, inhibits, CREBL2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CREBL2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
49,ZEB2,2.887940963654249e-21,False,,"Path 1: No (Pralsetinib, inhibits, ZEB2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ZEB2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
50,FOXD2,2.786665864682272e-21,False,,"Path 1: No (Pralsetinib, inhibits, FOXD2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FOXD2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
51,MAST3,2.6968317479473478e-21,False,,"Path 1: No (Pralsetinib, inhibits, MAST3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (MAST3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
52,FCMR,2.653502508809914e-21,False,,"Path 1: No (Pralsetinib, inhibits, FCMR) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FCMR, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
53,PPM1F,2.5878450476885174e-21,False,,"Path 1: No (Pralsetinib, inhibits, PPM1F) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PPM1F, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
54,ZNF292,2.4240267337441136e-21,False,,"Path 1: No (Pralsetinib, inhibits, ZNF292) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ZNF292, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
55,PRMT3,2.344469568716272e-21,False,,"Path 1: No (Pralsetinib, inhibits, PRMT3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRMT3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
56,ADCY3,2.1483716218883014e-21,False,,"Path 1: No (Pralsetinib, inhibits, ADCY3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ADCY3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
57,TOM1,2.081479044403044e-21,False,,"Path 1: No (Pralsetinib, inhibits, TOM1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TOM1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
58,H2BC12,1.763653271333191e-21,False,,"Path 1: No (Pralsetinib, inhibits, H2BC12) edge in KG; GNN predicts link (score=0.0000). Path 2: No (H2BC12, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
59,SMARCA5,1.6871834933182179e-21,False,,"Path 1: No (Pralsetinib, inhibits, SMARCA5) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SMARCA5, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
60,DNAJA2,1.4339274873318688e-21,False,,"Path 1: No (Pralsetinib, inhibits, DNAJA2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (DNAJA2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
61,TYROBP,1.339078184236558e-21,False,,"Path 1: No (Pralsetinib, inhibits, TYROBP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TYROBP, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
62,SCN2B,1.1310116649981232e-21,False,,"Path 1: No (Pralsetinib, inhibits, SCN2B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SCN2B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
63,GAS2,1.058732518060076e-21,False,,"Path 1: No (Pralsetinib, inhibits, GAS2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (GAS2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
64,DTNB,9.040735734228849e-22,False,,"Path 1: No (Pralsetinib, inhibits, DTNB) edge in KG; GNN predicts link (score=0.0000). Path 2: No (DTNB, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
65,CENPA,8.345412275350425e-22,False,,"Path 1: No (Pralsetinib, inhibits, CENPA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CENPA, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
66,SLC28A2,8.013589863146093e-22,False,,"Path 1: No (Pralsetinib, inhibits, SLC28A2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SLC28A2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
67,LILRB3,7.31789229487198e-22,False,,"Path 1: No (Pralsetinib, inhibits, LILRB3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (LILRB3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
68,AHCYL1,6.003893879456796e-22,False,,"Path 1: No (Pralsetinib, inhibits, AHCYL1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (AHCYL1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
69,ZBED4,5.827459647532216e-22,False,,"Path 1: No (Pralsetinib, inhibits, ZBED4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ZBED4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
70,PHF2,4.7236869835599145e-22,False,,"Path 1: No (Pralsetinib, inhibits, PHF2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PHF2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
71,AKAP8,4.347715623696092e-22,False,,"Path 1: No (Pralsetinib, inhibits, AKAP8) edge in KG; GNN predicts link (score=0.0000). Path 2: No (AKAP8, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
72,CNOT3,3.8901227823440936e-22,False,,"Path 1: No (Pralsetinib, inhibits, CNOT3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CNOT3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
73,DNAJB6,3.2570337593471333e-22,False,,"Path 1: No (Pralsetinib, inhibits, DNAJB6) edge in KG; GNN predicts link (score=0.0000). Path 2: No (DNAJB6, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
74,RRP9,3.137676201379063e-22,False,,"Path 1: No (Pralsetinib, inhibits, RRP9) edge in KG; GNN predicts link (score=0.0000). Path 2: No (RRP9, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
75,CDH16,2.7678382666077687e-22,False,,"Path 1: No (Pralsetinib, inhibits, CDH16) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CDH16, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
76,FNTB,2.649738342249238e-22,False,,"Path 1: No (Pralsetinib, inhibits, FNTB) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FNTB, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
77,PPFIA2,2.3912014867931728e-22,False,,"Path 1: No (Pralsetinib, inhibits, PPFIA2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PPFIA2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
78,HTATSF1,2.2883075190259374e-22,False,,"Path 1: No (Pralsetinib, inhibits, HTATSF1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (HTATSF1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
79,MACROH2A1,2.1041748881906145e-22,False,,"Path 1: No (Pralsetinib, inhibits, MACROH2A1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (MACROH2A1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
80,FLNB,1.8870555021780598e-22,False,,"Path 1: No (Pralsetinib, inhibits, FLNB) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FLNB, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
81,NCOR1,1.6856580508976868e-22,False,,"Path 1: No (Pralsetinib, inhibits, NCOR1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (NCOR1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
82,DNPH1,1.6633271026104353e-22,False,,"Path 1: No (Pralsetinib, inhibits, DNPH1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (DNPH1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
83,VAMP4,1.5298055155346857e-22,False,,"Path 1: No (Pralsetinib, inhibits, VAMP4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (VAMP4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
84,SEC22B,1.3741260246998534e-22,False,,"Path 1: No (Pralsetinib, inhibits, SEC22B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SEC22B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
85,KATNA1,1.2559618555092017e-22,False,,"Path 1: No (Pralsetinib, inhibits, KATNA1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (KATNA1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
86,BCAR3,1.2501731310778173e-22,False,,"Path 1: No (Pralsetinib, inhibits, BCAR3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BCAR3, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
87,PPP1R15A,1.2224061107382515e-22,False,,"Path 1: No (Pralsetinib, inhibits, PPP1R15A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PPP1R15A, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
88,BLTP3B,1.221399398005445e-22,False,,"Path 1: No (Pralsetinib, inhibits, BLTP3B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BLTP3B, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
89,SYT7,1.2053197621843991e-22,False,,"Path 1: No (Pralsetinib, inhibits, SYT7) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SYT7, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
90,PALM,1.1944627642091508e-22,False,,"Path 1: No (Pralsetinib, inhibits, PALM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PALM, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
91,SURF6,1.1770573371963543e-22,False,,"Path 1: No (Pralsetinib, inhibits, SURF6) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SURF6, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
92,EIF3G,1.1729336772548382e-22,False,,"Path 1: No (Pralsetinib, inhibits, EIF3G) edge in KG; GNN predicts link (score=0.0000). Path 2: No (EIF3G, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
93,NR1I2,1.1718021351723892e-22,False,,"Path 1: No (Pralsetinib, inhibits, NR1I2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (NR1I2, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
94,TOM1L1,1.146444737799475e-22,False,,"Path 1: No (Pralsetinib, inhibits, TOM1L1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TOM1L1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
95,PSIP1,1.1165601623548067e-22,False,,"Path 1: No (Pralsetinib, inhibits, PSIP1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PSIP1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
96,REM1,1.1011296643954492e-22,False,,"Path 1: No (Pralsetinib, inhibits, REM1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (REM1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
97,RPA1,1.094947140600179e-22,False,,"Path 1: No (Pralsetinib, inhibits, RPA1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (RPA1, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
98,WBP4,1.0870936200810328e-22,False,,"Path 1: No (Pralsetinib, inhibits, WBP4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (WBP4, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
99,JRK,1.0819181876718036e-22,False,,"Path 1: No (Pralsetinib, inhibits, JRK) edge in KG; GNN predicts link (score=0.0000). Path 2: No (JRK, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
100,CBLIF,1.0762664094935658e-22,False,,"Path 1: No (Pralsetinib, inhibits, CBLIF) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CBLIF, associated_with, outcome) edges in KG. GNN top predicted outcomes: —."
